Research ArticleGastrointestinal, Hepatic, Pulmonary, and Renal
Development and Characterization of a novel, high-affinity, specific, radiolabeled ligand for BRS-3 receptors.
Irene Ramos-Alvarez, Lingaku Lee, Samuel A Mantey and Robert T. Jensen
Journal of Pharmacology and Experimental Therapeutics April 10, 2019, jpet.118.255141; DOI: https://doi.org/10.1124/jpet.118.255141
Irene Ramos-Alvarez
1 NIH/NIDDK/DDB;
Lingaku Lee
2 DDB, NIDDK,NIH;
Samuel A Mantey
1 NIH/NIDDK/DDB;
Robert T. Jensen
3 NIH/ NIDDK/ DDB
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleGastrointestinal, Hepatic, Pulmonary, and Renal
Development and Characterization of a novel, high-affinity, specific, radiolabeled ligand for BRS-3 receptors.
Irene Ramos-Alvarez, Lingaku Lee, Samuel A Mantey and Robert T. Jensen
Journal of Pharmacology and Experimental Therapeutics April 10, 2019, jpet.118.255141; DOI: https://doi.org/10.1124/jpet.118.255141
Research ArticleGastrointestinal, Hepatic, Pulmonary, and Renal
Development and Characterization of a novel, high-affinity, specific, radiolabeled ligand for BRS-3 receptors.
Irene Ramos-Alvarez, Lingaku Lee, Samuel A Mantey and Robert T. Jensen
Journal of Pharmacology and Experimental Therapeutics April 10, 2019, jpet.118.255141; DOI: https://doi.org/10.1124/jpet.118.255141
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement